Valuation: Peptron, Inc.

Market Cap 2,462B 1.85B 1.65B 1.53B 1.38B 2.61B 175B 2.64B 18.34B 7.2B 91.99B 6.96B 6.81B 293B P/E 2024
-96x
P/E 2025 -427x
Enterprise Value 2,385B 1.8B 1.6B 1.48B 1.34B 2.53B 170B 2.56B 17.77B 6.97B 89.1B 6.74B 6.6B 284B EV / Sales 2024
716x
EV / Sales 2025 1,037x
Free-Float
91.5%
Yield 2024 *
-
Yield 2025 -
1 day+4.35%
1 week+18.12%
Current month-19.76%
1 month-34.57%
3 months-0.66%
6 months-58.51%
Current year-58.43%
1 week 87,400
Extreme 87400
109,300
1 month 79,200
Extreme 79200
150,900
Current year 79,200
Extreme 79200
359,000
1 year 79,200
Extreme 79200
392,500
3 years 21,100
Extreme 21100
392,500
5 years 7,050
Extreme 7050
392,500
10 years 7,050
Extreme 7050
392,500
Manager TitleAgeSince
Chief Executive Officer 65 2021-03-29
Chief Executive Officer 60 1997-11-20
Director of Finance/CFO 60 -
Director TitleAgeSince
Director/Board Member 60 2015-03-30
Director/Board Member 60 1999-06-30
Director/Board Member 65 2021-03-29
Date Insider Type Main position Quantity % Market Cap. Importance
11/27/24 Exercice

Chief Executive Officer

111,462 0.4799%
11/27/24 Exercice

Chief Financial Officer

8,709 0.0375%
11/27/24 Exercice

Chief Financial Officer

8,545 0.0368%
Change 5-day change 1-year change 3-year change Capi.($)
+4.35%+18.12%-61.25%+246.80% 1.85B
-0.21%-4.43%+44.40%+74.13% 66.22B
-3.43%+0.13%+7.11%+68.46% 55.2B
+0.32%+3.97%+12.11%+91.64% 52.79B
+3.28%+5.58%+26.51%+50.05% 45.53B
+0.51%+9.95%+22.40%+133.92% 43.94B
-1.15%+0.39%+263.21%+594.60% 41.64B
+0.10%+9.90%+16.11%+59.33% 34B
-8.54%-7.15%+26.07%-2.15% 25.84B
-0.76%+2.85%+35.47%+25.47% 23.51B
Average -0.55%+5.63%+39.21%+134.23% 39.05B
Weighted average by Cap. -0.74%+3.80%+48.82%+126.67%

Financials

2024 2025
Net sales 3.15B 2.37M 2.12M 1.96M 1.77M 3.34M 224M 3.38M 23.48M 9.21M 118M 8.91M 8.72M 375M 5.63B 4.24M 3.78M 3.5M 3.17M 5.97M 400M 6.04M 41.98M 16.47M 211M 15.92M 15.59M 671M
Net income -22.03B -16.6M -14.79M -13.69M -12.39M -23.34M -1.57B -23.62M -164M -64.41M -823M -62.25M -60.96M -2.62B -13.82B -10.41M -9.28M -8.59M -7.77M -14.65M -983M -14.82M -103M -40.41M -516M -39.06M -38.24M -1.65B
Net Debt -115B -86.36M -76.95M -71.25M -64.48M -121M -8.15B -123M -854M -335M -4.28B -324M -317M -13.65B -77.36B -58.27M -51.92M -48.07M -43.5M -81.96M -5.5B -82.93M -576M -226M -2.89B -219M -214M -9.21B
Projected Income Statement - Annual - Peptron, Inc.
Logo Peptron, Inc.
Peptron Inc is a Korea-based company principally engaged in the development, manufacture and distribution of sustained-release medications. The Company mainly develops the sustained-release medications and produces peptides as drug materials mainly for prostate cancer, hyperpituitarism, diabetes and neurodegenerative disorders. The Company also provides peptide synthesis services and manufactures raw material medicines. The Company distributes its products within domestic market and to overseas markets.
Employees
-
Date Price Change Volume
26-10-21 ₩105,600.00 +4.35% 233,741
26-10-20 ₩101,200.00 +0.40% 182,663
26-10-19 ₩100,800.00 +1.61% 275,778
26-10-16 ₩99,200.00 +12.34% 410,861
26-10-15 ₩88,300.00 -1.23% 299,067
Trader
-
Investor
-
Global
-
Quality
-
ESG MSCI
CCC
  1. Stock Market
  2. Stocks
  3. A087010 Stock